Nerve growth factor (NGF) autoantibodies and NGF in the synovial fluid: Implications in spondylarthropathies

Autoimmunity

Volumn 24, Issue 1, 1996, Pages 1-9

  Dicou, Eleni ^a   Perrot, Serge ^b   Menkes, Charles J ^b   Masson, Charles ^a   Nerriere, Veronique ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b Université Paris Descartes   (France)

Author keywords

NGF autoantibodies; NGF synovial fluid; Rheumatic disorders; Spondylarthropathy

Indexed keywords

AUTOANTIBODY; CALCIUM PYROPHOSPHATE; NERVE GROWTH FACTOR;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; NERVE GROWTH; OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYNOVIAL FLUID;

EID: 0029862306     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939608995352     Document Type: Article

References (13)

1. Dicou, E., Nerriere, V., Labropoulou, V. Naturally occurring antibodies against nerve growth factor in human and rabbit sera: comparison between control and herpes simplex virus-infected patients. J. Neuroimmunol. 1991; 34: 153-158.
2. Dicou, E., Hurez, D., Nerriere, V. Natural autoantibodies against the nerve growth factor in autoimmune diseases. J Neuroimmunol. 1993; 47: 159-168.
3. Dicou, E., Masson, C., Jabbour, W., Nerriere, V. Increased frequency of NGF in sera of rheumatoid arthritis and systemic lupus erythematosus patients. NeuroReport 1993; 5: 321-324.
4. Levi-Montalcini, R., Aloe, L., Alleva, E. A role for nerve growth factor in nervous endocrine and immune systems. Prog. NeuroEndocrinol Immunol. 1990 3: 1-10.
5. Aloe, L., Skaper, S. D., Leon, A., Levi-Montalcini, R. Nerve growth factor and autoimmune diseases. Autoimmunity 1994; 19: 141-150.
6. Aloe, L., Tuveri, M. A., Carcassi, U., Levi-Montalcini, R. Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum. 1992; 35: 351-355.
7. Dougados, M., van der Linden, S., Julhin, R. et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991; 34: 1218-1227.
8. Arnette, F. C., Edworthy, S. M., Bloch, D. A. et al. The American Rheumatism Association 1987 criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988; 31: 315-324.
9. McCarty, D. J. Calcium pyrophosphate dihydrate crystal deposition disease. In: Schumacher, H. R., ed. Primer on the Rheumatic Diseases. Atlanta, Arthritis Foundation, 1993: 219-222.
10. Altman, R., Asch, T., Bloch, D. et al. Development of criteria for the classification and reporting of osteoarthritis. Arthritis Rheum. 1986; 29: 1039-1049.
11. Mobley, W. C., Shenker, A., Shooter, E. M. Characterisation and isolation of proteolytically modified nerve growth factor. Biochem. 1976; 15: 5543-5551.
12. Dicou, E. Expression of recombinant human nerve growth factor in Escherichia coli. Neurochem. Int. 1992; 20: 129-134.
13. Dicou, E., Nerriere, V., Naud, M. C., deKozak, Y. NGF involvement in ocular inflammation: secretion by rat resident cells. NeuroReport 1994; 6: 26-28.